SCHEMBL28822159

SCHEMBL28822159

Cc1c(C(=O)O)cccc1C(=O)O.O=[N+]([O-])c1cnccc1N1CCNCC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.48
▸ MAPT P10636 7/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ KMT2A Q03164 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ HTR6 P50406 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ HTT P42858 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ PIM3 Q86V86 1/20 0.38
▸ ADRB1 P08588 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4437996 0.84 MAPT (0.53) MAPTPOLBSMN1; SMN2HTR6ALDH1A1
Pivalate SCHEMBL27791210 0.83 MAPT (0.45) MAPTPOLBKMT2ASMN1; SMN2MEN1
SCHEMBL14216407 0.79 MAPT (0.56) MAPTPOLBSMN1; SMN2HTR6ALDH1A1
Tert-Butyl Formate SCHEMBL27770095 0.75 MAPT (0.43) MAPTPOLBKMT2ASMN1; SMN2HTR6
SCHEMBL3952822 0.73 KMT2A (0.48) MAPTPOLBKMT2ASMN1; SMN2MEN1
SCHEMBL13736235 0.73 KMT2A (0.48) MAPTPOLBKMT2ASMN1; SMN2MEN1
SCHEMBL27629620 0.73 ADRB1 (0.67) HTR6ADRB1
Biphenyl SCHEMBL27395942 0.72 HTR6 (0.48) HTR6ALDH1A1PIM1PIM3
SCHEMBL9425659 0.72 MAPT (0.67) MAPTKDM4EPOLBKMT2ASMN1; SMN2
Acetic Acid SCHEMBL4628540 0.71 KMT2A (0.55) MAPTKMT2ASMN1; SMN2MEN1HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104903325-A COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMA 2015-09-09 — — CN disclosed
Send feedback